Bussolino F et al. |
Chick retina generates platelet-activating factor. |
1987 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2890284
|
Mallet AI et al. |
Platelet activating factor in chronic plaque psoriasis. |
1987 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2960170
|
Bourgain RH et al. |
Effect of ginkgolide PAF-acether antagonists on arterial thrombosis. |
1987 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2960196
|
Braquet P et al. |
Platelet-activating factor: a potential mediator of shock. |
1987 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2960197
|
Myers A et al. |
Pharmacological manipulation of platelet-activating factor toxicity in rodents. |
1987 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2960198
|
Izumi T et al. |
Regulation and signal transduction of PAF receptor. |
1995 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:7732892
|
Bennett SA and Birnboim HC |
Platelet activating factor induces transformation of human fibroblasts. |
1995 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:7732893
|
Vargaftig BB et al. |
Synergized activation of human platelets by epinephrine and platelet-activating factor-acether is adenosine diphosphate and thromboxane A2-independent. |
1983 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:6221558
|
Voelkel NF et al. |
Platelet-activating factor causes pulmonary vasoconstriction and edema via platelet-independent leukotriene formation. |
1983 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:6221590
|
Summers JB et al. |
ABT-299, a potent antagonist of platelet activating factor. |
1995 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:7732895
|
Livio M et al. |
A platelet-activating factor receptor antagonist protects against renal function deterioration in nephrotoxic nephritis. |
1987 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2823570
|
Shen TY et al. |
Recent development of platelet-activating factor antagonists. |
1989 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2546389
|
Handley DA et al. |
Chemistry and pharmacology of PAF antagonists. Evaluation of changes at potential metabolism sites on activity and duration of activity. |
1989 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2546390
|
Dray F et al. |
Recent studies on icosanoids and PAF-acether modulation of some central neurosecretions in the rat. |
1989 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2546391
|
Takatani M et al. |
Platelet activating factor (PAF) antagonists: development of a highly potent PAF antagonist, TCV-309. |
1991 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:1825438
|
Kawabe T et al. |
Role of PAF and cytokines in the modulation of Fc epsilon RII/CD23 expression on human eosinophils. |
1991 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:1825444
|
Weber PC and Sellmayer A |
Modification of the eicosanoid system and cell signalling by precursor fatty acids. |
1991 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:1825543
|
Balazy M et al. |
A novel method for the analysis of PAF and alkyl-ether phospholipids by mass spectrometry. |
1991 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:1825562
|
Magni F et al. |
Determination of platelet-activating factor in biological samples by high resolution mass spectrometry. |
1991 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:1825563
|
Coceani F et al. |
Leukotrienes in cerebrospinal fluid of the conscious cat: effect of platelet-activating factor and pyrogens. |
1991 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:1825586
|